DIPYRIDAMOLE

SynDRA canonical compound SYN0002662 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	PDE5A
Mechanism of action	Phosphodiesterase inhibitor
Indication	coronary artery disease (CAD) \| hypertension \| peripheral artery disease (PAD)
Disease area	cardiology

All known targets

PDE8B
SLC29A1
PDE5A
PDE7B
PDE8A
PDE10A
PDE4A
PDE6A
PDE6D
PDE6C
PDE6B
PDE7A

Mechanisms of action (all sources)

Phosphodiesterase inhibitor
SLC29A1 INHIBITOR
Equilibrative nucleoside transporter 1 inhibitor
PDE5A INHIBITOR
3',5'-cyclic phosphodiesterase inhibitor
PDE4A INHIBITOR
PDE3A INHIBITOR
PDE6H INHIBITOR
PDE6G INHIBITOR
PDE2A INHIBITOR
PDE7A INHIBITOR
PDE1A INHIBITOR

Drug classes

Platelet Aggregation Inhibitor
Cardiovascular Agents
Enzyme Inhibitors
Hematologic Agents
Phosphodiesterase Inhibitors
Platelet Aggregation Inhibitors
Vasodilator Agents

ATC classes

B01A · ANTITHROMBOTIC AGENTS

Cross-references

PubChem CID: 3108
ChEMBL: CHEMBL932
DrugBank: DB00975
ChEBI: CHEBI:4653
KEGG: D00302
RxNorm: 3521
PDB: H9F
Wikipedia: Dipyridamole
TTD: D0F9GE
LINCS BRD: BRD-K86301799

Synonyms

Reported adverse events

Headache
Rash
Dizziness

Look up DIPYRIDAMOLE in the interactive SynDRA portal →